POY_1170x120_8-12-19

Rusty Field

Upsher-Smith acquires two products from Dr. Reddy’s

Upsher-Smith acquires two products from Dr. Reddy’s

MAPLE GROVE, Minn. – Upsher-Smith recently announced that it has completed the acquisition of Tosymra (sumatriptan) Nasal Spray, 10 mg, and Zembrace SymTouch (sumatriptan) Injection 3 mg from Dr. Reddy’s Laboratories. The products were previously commercialized through Dr. Reddy’s wholly owned subsidiary, Promius Pharma. Both medications are indicated for the acute treatment of migraine with

Upsher-Smith to commercialize Klor-Con and Potassium Chloride product families

Upsher-Smith to commercialize Klor-Con and Potassium Chloride product families

MAPLE GROVE, Minn. — Upsher-Smith announced that effective July 1, 2019 it will commercialize the Klor-Con (potassium chloride) and Potassium Chloride product families and will continue its role as manufacturer. “Upsher-Smith is looking forward to commercializing our full line of Klor-Con and Potassium Chloride products,” said Rusty Field, president and chief executive officer, Upsher-Smith. “Our

Upsher-Smith, NASPA honor pharmacists

Upsher-Smith, NASPA honor pharmacists

MAPLE GROVE, MN – Upsher-Smith and the National Alliance of State Pharmacy Associations (NASPA) recently recognized the recipients of the 2018 NASPA Excellence in Innovation Award. Forty pharmacists from across the nation were recognized for their outstanding contributions to the profession of pharmacy. The annual award is coordinated by NASPA and sponsored by Upsher-Smith. Founded

Upsher-Smith celebrates 100 years of serving patients

Upsher-Smith celebrates 100 years of serving patients

MAPLE GROVE, Minn. – Upsher-Smith proudly kicked off its centennial anniversary this month at its headquarters here. Employees came together on January 10, 2019 to mark 100 years of Upsher-Smith’s heritage of formulating and manufacturing quality generics that has ledto improving the lives of hundreds of thousands of patients. In 1919, a young English-born pharmacist,

Jim Spoon named NCPA 2018 Independent Pharmacist of the Year

Jim Spoon named NCPA 2018 Independent Pharmacist of the Year

BOSTON – Jim Spoon, owner of Spoon Drug in Sand Springs, Okla., has been named the National Community Pharmacists Association 2018 Willard B. Simmons Independent Pharmacist of the Year. The award is sponsored by Upsher-Smith Laboratories. Spoon received the award at NCPA’s recent 2018 Annual Convention in Boston. The Independent Pharmacist of the Year award recognizes an independent pharmacist

Upsher-Smith adds to generic portfolio

Upsher-Smith adds to generic portfolio

MAPLE GROVE, MN – Upsher-Smith Laboratories, LLC (Upsher-Smith) has added another product to its growing generic portfolio, supporting its commitment to expanding and diversifying its product offerings. Upsher Smith has launched four new products and two line extensions this year. Upsher-Smith’s Bexarotene Capsules, 75 mg, an AB-rated generic version of the branded product, Targretin (bexarotene)

Upsher-Smith launches vigabatrin under brand name Vigadrone

Upsher-Smith launches vigabatrin under brand name Vigadrone

MAPLE GROVE, Minn. —  Upsher-Smith Laboratories  announced the launch of Vigadrone (vigabatrin) for Oral Solution, 500 mg, a fully substitutable, AA-rated generic version of Sabril (vigabatrin) powder for oral solution. The product was approved by the U.S. Food and Drug Administration (FDA) on June 21, 2018. The Vigabatrin powder market had U.S. sales of approximately $333 million for the 12 months

Upsher-Smith parent sells stake in U.S. generics unit

Upsher-Smith parent sells stake in U.S. generics unit

MAPLE GROVE, Minn. — Upsher-Smith Laboratories LLC said its Japan-based parent, Sawai Pharmaceutical Co., has agreed to sell a 20% stake in its Sawai America Inc. subsidiary to Sumitomo Corp. of Americas (SCOA). Under the deal, SCOA — part of global conglomerate Sumitomo Corp. — is slated to buy the interest in Sawai America for $211

Upsher-Smith goes live with new Qudexy XR website

Upsher-Smith goes live with new Qudexy XR website

MAPLE GROVE, Minn. — Upsher-Smith Laboratories LLC has launched an enhanced website for its Qudexy XR anti-epileptic and migraine medication. Upsher-Smith said Monday that QudexyXR.com features the company’s Access Pathways Program aimed at reducing the barriers associated with prescribing Qudexy XR (topiramate). QudexyXR.com also offers health care providers tools necessary to help their patients “Start,

HDA honors drug companies with 2017 DIANA awards

HDA honors drug companies with 2017 DIANA awards

PHOENIX — The Healthcare Distribution Alliance (HDA) this week presented its annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA) to pharmaceutical manufacturers for supply chain innovation and collaboration. Given at the HDA 2017 Business and Leadership Conference in Phoenix, the DIANA awards honor HDA member manufacturers that develop innovative new products and promotions

Sawai wraps up acquisition of Upsher-Smith generics unit

Sawai wraps up acquisition of Upsher-Smith generics unit

TOKYO and MINNEAPOLIS — Sawai Pharmaceutical Co. Ltd. has closed its $1.05 billion acquisition of the Upsher-Smith Laboratories generic drug business. Sawai, which unveiled the deal with Upsher-Smith parent Acova Inc. in April, plans to retain Upsher’s headquarters in Minnesota and operation in Colorado. And as previously announced, Upsher-Smith will retain its current leadership, with

Upsher-Smith releases Anafranil generic

Upsher-Smith releases Anafranil generic

MAPLE GROVE, Minn — Upsher-Smith Laboratories Inc. has launched clomipramine hydrochloride capsules, an antidepressant, in the United States. Upsher-Smith said its clomipramine hydrochloride comes in dosages of 25 mg, 50 mg and 75 mg in 100-count bottles and is a generic version of Anafranil capsules from Mallinckrodt Pharmaceuticals. A tricyclic antidepressant, Anafranil is indicated for

Upsher-Smith, NASPA honor pharmacists

Upsher-Smith, NASPA honor pharmacists

MAPLE GROVE, Minn. — Upsher-Smith Laboratories Inc. and the National Alliance of State Pharmacy Associations (NASPA) have recognized the efforts 43 pharmacists from across the nation with the 2016 NASPA Excellence in Innovation Award. Upsher-Smith said Wednesday that the pharmacists were honored for their outstanding contributions to the pharmacy profession. Sponsored by Upsher-Smith, the award is

Upsher-Smith rolls out Qudexy XR savings program

Upsher-Smith rolls out Qudexy XR savings program

MAPLE GROVE, Minn. — Upsher-Smith Laboratories Inc. has launched a new savings and support program for Qudexy XR extended-release capsules, a once-daily, broad-spectrum anti-epileptic medication. Dubbed the “It’s That Simple” program, the initiative is designed to make it easier for doctors to prescribe Qudexy XR (topiramate) and includes a $0 co-payment for eligible patients. Qudexy XR is